Blueprint for an Innovation Economy in Florida Research as Economic Foundation | Page 25

BIT A Post Material Revenue - R&D Mostly AxoGen Funded. Outcome: Product Line Scaling Microsurgery, Peer Review of Clinical Research at 12 Sites Oral and Maxillofacial Surgery, Shanti R, Zaccardi V Exp Neurology, Neurbauer D, Muir D, et.al. Krekoski .al. J of Neurodegeneration & Regeneration, Graham JB, Muir D, J, Exp Neurology, Neubaurer D, Muir D, et.al. Shirley Pincus Surgery Annals of Plastic Surgery, Duic I, Rose F, et.al. Exp Neurology, Muir D Scale Product Line, Face & Breast Reconstruction, Podiatry, Prostatectomy, Pain Journal of Hand Surgery, Cho M, Rinker B, et.al. Hand, Karabekmez F, Microsurgery, Brooks D, Weber R, et.al. Duymaz A, et.al. Exp Neurology, Graham JB, Muir D, Gen, Muir D, Grant K, 7 Grants, 10 YR* Debt Financing, $2.62M DOD, Muir D, Venture, $18M Grant $1M, 3 YR Equity Raise Debt Financing, $3M Post IPO, $17.5M Equity Raise Post IPO, $13M Equity Raise Debt Financing, $3.7M Series C, $12.1M Equity Raise Investors, Raise ue - R&D Mostly AxoGen Funded. Outcome: Efficacy & Surgical Techniques FY Fin, Rev $4.85M, GP $2.42M FY Fin, Rev $10.9M, FY Fin, Rev $27.33M, GP $8.5M, GM 78% GM 82.3% FY Fin, Rev $7.69M, GP $5.73M GM 75% *LECTEC Merger/IPO, Initial Public Offering FY Fin, Rev $16.8M, GP $13.4, GM 79.5% 2nd QTR To Date Fin, Rev $18.5M, GM 84% 23